Back to Screener

Consumer Cyclical

MEDIROM Healthcare Technologies Inc.(MRM)

Live Price

Offline

$0.997

-1.29% today

1Y Change

-29.79%

Window

Jun 30, 2025 → Jun 26, 2026

Market Cap
$980.00M
Revenue Growth
-92.4%
EPS Growth
-74.5%
Dividend Yield
0.0%

Coverage: 249 bars · Jun 30, 2025 → Jun 26, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

MEDIROM Healthcare Technologies Inc. (MRM) is a Consumer Cyclical stock with a market cap of $980.00M and listed on NASDAQ. The stock last traded around $1.00 and down 29.8% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of -92.4%, EPS growth of -74.5%, a dividend yield of 0.0%. What stands out right now is revenue -92.4%, EPS -74.5%, free cash flow 0.0% with operating margin 10.3% and ROIC 1.7%. Valuation is more restrained than many high-expectation growth names at P/E 25.8 and price/sales 1.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MRM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.

Benchmark Edge

MRM vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

MRM trails SPY

MRM is 47.78 pts behind over the shared 1Y window.

MRM had 59.91 pts deeper max drawdown than SPY.

MRM beat SPY in 1 of 2 calendar years shown and trailed in 1.

MRM

-29.79%

Normalized return

SPY

+17.99%

S&P 500

Excess Return

-47.78 pts

Relative to SPY

MRM Max Drawdown

-69.05%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

MRMSPY

Calendar-Year Returns

Uses the longest available daily history for MRM and SPY.

YearMRMSPYExcessLeader
2026-49.13%+6.71%-55.84 ptsSPY
2025+39.44%+11.19%+28.24 ptsMRM

Unable to load analyst forecasts.

Timed out loading forecasts for MRM

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.